Nalaganje...

Clinical use of abiraterone in the treatment of metastatic castration-resistant prostate cancer

Prostate cancer remains the most common type of cancer among men in the United States. Treatment for metastatic prostate cancer has improved significantly over the years with more and more agents improving overall survival. This review will address the pathophysiology of prostate cancer followed by...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Zobniw, Chrystia M, Causebrook, Alanna, Fong, Mei Ka
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4128838/
https://ncbi.nlm.nih.gov/pubmed/25157341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/RRU.S29003
Oznake: Označite
Brez oznak, prvi označite!